Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical…

U.S. National Institutes of Health·United States of America

NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)

Closes 7/9/2026$500k – $5MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

This opportunity is for multi-center clinical trials focused on neurological emergencies. The successful applicants will collaborate with the NIH SIREN Network to conduct the proposed trial. The NIH SIREN Clinical Coordinating Center (CCC) and the SIREN Data Coordinating Center (DCC) will provide support for the trial. The applicants do not need to be part of the existing SIREN infrastructure to apply. The key aspects of this opportunity include: • Collaboration with the NIH SIREN Network • Conducting multi-center clinical trials for neurological emergencies • Support from the NIH SIREN Clinical Coordinating Center (CCC) and the SIREN Data Coordinating Center (DCC) • No requirement to be part of the existing SIREN infrastructure • Eligibility for various types of organizations, including state governments, private institutions of higher education, and non-profits.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

[email protected]

301-402-2541

Key dates

Opened
2/8/2023
Closes
7/9/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-049

Budget estimate

$500,000 – $5,000,000

The budget for this opportunity is difficult to estimate as the document does not provide a specific amount. However, considering the nature of the project, which involves clinical trials and research, the budget could be substantial. Factors that may influence the payment range include the scope of the project, the number of participants, and the duration of the trial. A rough estimate could be in the range of $500,000 to $5 million, but this is highly speculative and may not reflect the actual budget.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 82%

Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)

Closes 11/9/2026Opened 3/16/2026

U.S. National Institutes of Health·United States of America

80% match

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

Closes 3/9/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

80% match

Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Closes 2/15/2027Opened 7/1/2026

U.S. National Institutes of Health·United States of America

79% match

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

Closes 11/19/2026Opened 12/28/2023

U.S. National Institutes of Health·United States of America

78% match

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Closes 1/6/2028Opened 10/23/2024

U.S. National Institutes of Health·United States of America

77% match

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Closes 3/4/2027Opened 5/23/2024

U.S. National Institutes of Health·United States of America

77% match

Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure ? Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC)

Closes 3/3/2027Opened 8/13/2026

U.S. National Institutes of Health·United States of America

77% match

Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure ? Clinical Enrollment Hubs

Closes 3/3/2027Opened 8/13/2026

U.S. National Institutes of Health·United States of America

75% match

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

Closes 1/28/2028Opened 5/5/2025

U.S. National Institutes of Health·United States of America

75% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

75% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

75% match

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

Closes 1/6/2028Opened 10/10/2024

U.S. National Institutes of Health·United States of America

74% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

74% match

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

Closes 10/18/2027Opened 10/20/2023

U.S. National Institutes of Health·United States of America

74% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

74% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

74% match

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

Closes 11/15/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

74% match

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Closes 1/6/2028Opened 9/1/2021

U.S. National Institutes of Health·United States of America

74% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 5/24/2027Opened 9/23/2026

U.S. National Institutes of Health·United States of America

73% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

73% match

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Closes 7/5/2029Opened 6/27/2025

U.S. National Institutes of Health·United States of America

73% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

73% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

73% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

73% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026